Recommendations for the diagnosis and management of persons with suspected vaccine-induced immune thrombotic thrombocytopenia (VITT)

In recent months, rare cases of thrombosis at unusual sites associated with thrombocytopenia, occurring within a typical risk window (i.e., 4-28 days) after receiving SARS CoV2 vaccines, have been reported. Healthcare professionals should be prepared to detect these cases on time. The Expert Panel of the Knowledge Mana-gement and Transfer Network conducted a free search of the related literature. With the available information and the clinical expertise of the working group, we formulated, reviewed, and endorsed recommendations for the timely suspicion, diagnosis (case definitions, the use of initial laboratory and imaging tests, specific tests), and management of these thrombotic conditions. This document is considered a living document that will be updated as new evidence emerges, and re-commendations may change over time..

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:26

Enthalten in:

Infectio - 26(2021), 1, Seite 3-10

Sprache:

Englisch ; Spanisch

Beteiligte Personen:

Nancy Yomayusa [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
Journal toc [kostenfrei]

Themen:

Infectious and parasitic diseases
Therapeutics. Pharmacology
Thrombocytopenia; covid-19 vaccines; thrombosis

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ01222278X